ProfileGDS4718 / 206577_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 74% 75% 97% 53% 82% 27% 24% 73% 86% 77% 78% 82% 33% 26% 22% 96% 87% 45% 26% 96% 76% 80% 79% 61% 79% 42% 63% 24% 75% 31% 22% 87% 89% 35% 67% 47% 24% 93% 66% 98% 67% 42% 61% 42% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.2031974
GSM549102patient 115, normal, homogenized [OPG study]7.2561275
GSM549104patient 119, normal, homogenized [OPG study]10.929897
GSM549108patient 138, normal, homogenized [OPG study]5.6971953
GSM549119patient 077, normal, homogenized [OPG study]7.9760282
GSM549133patient 032, cancer, homogenized [OPG study]4.3719127
GSM549139patient 042, cancer, homogenized [OPG study]4.2815224
GSM549099patient 107, normal, homogenized [OPG study]7.034373
GSM549109patient 139, normal, homogenized [OPG study]8.4972186
GSM549110patient 046, normal, homogenized [OPG study]7.4932677
GSM549114patient 063, normal, homogenized [OPG study]7.6644678
GSM549122patient 082, normal, homogenized [OPG study]8.1170482
GSM549134patient 033, cancer, homogenized [OPG study]4.6538233
GSM549136patient 036, cancer, homogenized [OPG study]4.314126
GSM549140patient 044, cancer, homogenized [OPG study]4.1973822
GSM549111patient 047, normal, homogenized [OPG study]10.797696
GSM549113patient 057, normal, homogenized [OPG study]8.930687
GSM549132patient 031, cancer, homogenized [OPG study]5.2268245
GSM549137patient 038, cancer, homogenized [OPG study]4.3457626
GSM549142patient 047, cancer, homogenized [OPG study]10.163996
GSM549100patient 110, normal, homogenized [OPG study]7.384876
GSM549107patient 135, normal, homogenized [OPG study]7.8173280
GSM549115patient 068, normal, homogenized [OPG study]7.8964479
GSM549116patient 072, normal, homogenized [OPG study]6.1906361
GSM549120patient 078, normal, homogenized [OPG study]7.7634279
GSM549131patient 030, cancer, homogenized [OPG study]5.0554842
GSM549118patient 074, normal, homogenized [OPG study]6.3190563
GSM549129patient 027, cancer, homogenized [OPG study]4.3158824
GSM549123patient 088, normal, homogenized [OPG study]7.2965975
GSM549124patient 006, cancer, homogenized [OPG study]4.6152731
GSM549126patient 015, cancer, homogenized [OPG study]4.1896422
GSM549128patient 025, cancer, homogenized [OPG study]8.718487
GSM549103patient 117, normal, homogenized [OPG study]9.0064789
GSM549117patient 073, normal, homogenized [OPG study]4.7456135
GSM549138patient 041, cancer, homogenized [OPG study]6.6707567
GSM549141patient 045, cancer, homogenized [OPG study]5.2778847
GSM549130patient 028, cancer, homogenized [OPG study]4.3047124
GSM549101patient 111, normal, homogenized [OPG study]9.6324593
GSM549105patient 128, normal, homogenized [OPG study]6.5447766
GSM549106patient 134, normal, homogenized [OPG study]11.459798
GSM549112patient 048, normal, homogenized [OPG study]6.6372267
GSM549125patient 011, cancer, homogenized [OPG study]5.0899142
GSM549127patient 024, cancer, homogenized [OPG study]6.2146961
GSM549135patient 035, cancer, homogenized [OPG study]5.0442942